Saratov JOURNAL of Medical and Scientific Research

Effect of estrogen deficiency on the lipid profile in women in different age periods

Year: 2014, volume 10 Issue: №3 Pages: 396-400
Heading: Obstetrics and Gynecology Article type: Original article
Authors: Neyfeld I.V., Rogozhina I.E., Kirichuk V.F., Kiselev A.R., Zhirnyakov A.l., Bobyleva I.V.
Organization: Saratov Institute of Cardiology, Russia, Saratov State Medical University
Summary:

The aim of the study is to evaluate influence of estrogen deficiency on lipid profile in women of different age. Material and Methods. 189 women with normal body weight: 44 women with premature menopause (aged <40 years), 69 women with early menopause (aged 40-45 years), and 76 women with natural menopause (aged 46-55 years) have been studied. In all women identification of clinical status has been performed during clinical examination. Results. It is shown that increasing age associated with increasing total cholesterol, triglycerides, low-density lipoprotein (LDL), very low density lipoproteins (VLDL) (p<0.05). We have not observed a significant association between age and level of high-density lipoprotein (HDL) (p=0.117). According with increased age, atherogenic index of plasma (AIP) increases from initial -0.17±0.09 (M±o) to 0.09±0.47 (p<0.05) in women with premature menopause, and to 0.14±0.21 (p<0.05) in other women. Final level of AIP was similar between women aged 40-45 years and women aged 46-55 years (p=0.084). Conclusion. Lipid metabolism disorders were assessed in 73.5% of women with estrogen deficiency. According to the age factor the rate of women with normal lipid metabolism decreases (x2=10,165, p=0.026).

Bibliography:
1. de VilliersTJ, GassML, HainesCJ, etal. Global consensus statement on menopausal hormone therapy. Climacteric 2013; 16 (2): 203-204; 2. Kim ES, Menon V. Status of women in cardiovascular clinical trials. Arterioscler Thromb Vase Biol 2009; 29: 279-283; 3. Neufeld IW, Zhirnyakov Al, Skupova IN. Risk factors for cardiovascular disease in women. Bulletin of Medical Internet Conferences 2012; 2 (12): 994-996; 4. Smiley DA, Khalil RA. Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels. Curr Med Chem 2009; 16 (15): 1863-1887; 5. Smetnik WP. Medicine menopause. Yaroslavl: Litera, 2006; 848 p.; 6. Shuster LT, Rhodes DJ, Gostout BS, et al. Premature menopause or early menopause: Long-term health consequences. Maturitas2010; 65(2): 161-166; 7. Grady D, Herrington D, Bittner V, et al. HERS Research Group. Cardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002; 288 (1): 49-57; 8. Harman SM, Vittinghoff E, Brinton EA, et al. Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes. Am J Med 2011; 124 (3): 199-205; 9. Friedwald WT, Levy RJ, Fredrickson DS. Estimation of the concentration of low-density-lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18:499-502; 10. Dobiasova M. AlP-atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice. Vnitr Lek 2006; 52 (1): 64-71; 11. Roeters van Lennep JE, Westerveld HT, Erkelens DW, van der Wall ЕЕ. Risk factors for coronary heart disease: implications of gender. Cardiovascular Research 2002; 53 (3): 538-549; 12. Okonofua ЕЕ, Lawal A, Bamgbose JK. Features of Menopause and Menopausal age in Nigerian women. Int J Gynaecol Obstet 1990; 31 (4): 341-345.

AttachmentSize
2014_03_396-400.pdf486.89 KB

No votes yet